Consolidated Condensed Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Income Statement [Abstract]
Net revenue	$ 16,128	$ 12,859	$ 29,705	$ 25,526
Cost of sales	9,619	9,317	17,849	17,312
Gross profit	6,509	3,542	11,856	8,214
Research and development	3,368	3,684	6,743	7,324
Marketing, general, and administrative	1,175	1,144	2,213	2,321
Restructuring and other charges	170	1,890	4,240	2,046
Operating expenses	4,713	6,718	13,196	11,691
Operating income (loss)	1,796	(3,176)	(1,340)	(3,477)
Gains (losses) on equity investments, net	(39)	502	(111)	390
Interest and other, net	(12,576)	(95)	(13,314)	(268)
Income (loss) before taxes	(10,819)	(2,769)	(14,765)	(3,355)
Provision for (benefit from) taxes	29	255	364	556
Net income (loss)	(10,848)	(3,024)	(15,129)	(3,911)
Less: net income (loss) attributable to non-controlling interests	185	(106)	(368)	(172)
Net income (loss) attributable to Intel	$ (11,033)	$ (2,918)	$ (14,761)	$ (3,739)
Earnings (loss) per share attributable to Intel—basic (in dollars per share)	$ (2.16)	$ (0.67)	$ (2.89)	$ (0.86)
Earnings (loss) per share attributable to Intel—diluted (in dollars per share)	$ (2.16)	$ (0.67)	$ (2.89)	$ (0.86)
Weighted average shares of common stock outstanding:
Weighted average shares of common stock outstanding—basic (in shares)	5,104	4,369	5,108	4,356
Weighted average shares of common stock outstanding—diluted (in shares)	5,104	4,369	5,108	4,356

Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Millions

6 Months Ended

Jun. 27, 2026

Jun. 28, 2025

Statement of Cash Flows [Abstract]

Cash, cash equivalents, and restricted cash, beginning of period

$ 14,712

$ 8,249

Cash flows provided by (used for) operating activities:

Net income (loss)

(15,129)

(3,911)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation

5,891

5,213

Share-based compensation

1,307

1,348

Restructuring and other charges

3,967

382

Amortization of intangibles

469

474

(Gains) losses on equity investments, net

111

(390)

Mark-to-market (gains) losses on Escrowed Shares

13,619

Deferred taxes

(27)

106

Impairments and net (gain) loss on retirement of property, plant, and equipment

165

482

Changes in assets and liabilities:

Accounts receivable

(221)

1,004

Inventories

(874)

Accounts payable

310

114

Accrued compensation and benefits

(372)

1,022

Income taxes

(477)

(1,338)

Other assets and liabilities

(637)

(1,742)

Total adjustments

23,231

6,774

Net cash provided by (used for) operating activities

8,102

2,863

Cash flows provided by (used for) investing activities:

Additions to property, plant, and equipment

(6,192)

(8,733)

Proceeds from capital-related government incentives

167

964

Acquisitions, net of cash acquired

(596)

Purchases of short-term investments

(12,737)

(5,730)

Sales of short-term investments

11,009

1,948

Maturities of short-term investments

7,724

6,627

Proceeds from divestitures, net

1,935

Other investing

(44)

984

Net cash provided by (used for) investing activities

(669)

(2,005)

Cash flows provided by (used for) financing activities:

Issuance of commercial paper, net of issuance costs

3,493

Repayment of commercial paper

(1,496)

Payments on finance leases

(832)

(9)

Partner contributions

4,082

2,238

Partner distributions

(14,339)

(91)

Additions to property, plant, and equipment

(1,423)

(1,962)

Issuance of term debt, net of issuance costs

13,000

Repayment of term debt

(9,000)

(1,500)

Proceeds from sales of common stock through employee equity incentive plans

427

491

Restricted stock unit withholdings

(617)

(181)

Other financing

154

(397)

Net cash provided by (used for) financing activities

(8,548)

586

Net increase (decrease) in cash, cash equivalents, and restricted cash

(1,115)

1,444

Cash, cash equivalents, and restricted cash, end of period

^[1]

13,597

9,693

Non-cash supplemental disclosures:

Acquisition of property, plant, and equipment

^[2]

3,148

5,155

Recognition of capital-related government incentives

632

1,452

Cash paid during the period for:

Interest, net of capitalized interest

531

514

Income taxes, net of refunds

$ 904

$ 1,793

[1]	Includes $50 million cash recorded within other current assets on the Consolidated Condensed Balance Sheets relating to Altera cash held for sale at June 28, 2025
[2]	Includes $626 million with extended payment terms of greater than 90 days in the six months ended June 27, 2026 ($960 million in the six months ended June 28, 2025).

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Jun. 27, 2026	Dec. 27, 2025
Current assets:
Cash and cash equivalents	$ 12,874	$ 14,265
Short-term investments	16,853	23,151
Accounts receivable, net	4,033	3,839
Inventories	12,492	11,618
Other current assets	10,961	10,815
Total current assets	57,213	63,688
Property, plant, and equipment, net of accumulated depreciation of $109,918 ($106,464 as of December 27, 2025)	105,741	105,414
Equity investments	8,410	8,512
Goodwill	20,465	23,912
Identified intangible assets, net	2,545	2,772
Other long-term assets	8,065	7,131
Total assets	202,439	211,429
Current liabilities:
Accounts payable	8,756	9,882
Accrued compensation and benefits	3,748	3,990
Short-term debt	1,988	2,499
Other accrued liabilities	21,178	15,204
Total current liabilities	35,670	31,575
Debt	48,549	44,086
Other long-term liabilities	15,077	9,408
Contingencies (Note 14)
Stockholders’ equity:
Common stock and capital in excess of par value, 5,043 issued and outstanding (4,994 issued and outstanding as of December 27, 2025)	53,780	65,185
Accumulated other comprehensive income (loss)	(80)	113
Retained earnings	33,842	48,983
Total Intel stockholders' equity	87,542	114,281
Non-controlling interests	15,601	12,079
Total stockholders' equity	103,143	126,360
Total liabilities and stockholders’ equity	$ 202,439	$ 211,429